148 related articles for article (PubMed ID: 2284375)
1. Application of Piagetian measures of cognition in severe Alzheimer's disease.
Sclan SG; Foster JR; Reisberg B; Franssen E; Welkowitz J
Psychiatr J Univ Ott; 1990 Nov; 15(4):221-6. PubMed ID: 2284375
[TBL] [Abstract][Full Text] [Related]
2. Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment.
Levinoff EJ; Phillips NA; Verret L; Babins L; Kelner N; Akerib V; Chertkow H
Neuropsychology; 2006 Jan; 20(1):123-32. PubMed ID: 16460228
[TBL] [Abstract][Full Text] [Related]
3. The Severe Cognitive Impairment Rating Scale--an instrument for the assessment of cognition in moderate to severe dementia patients.
Choe JY; Youn JC; Park JH; Park IS; Jeong JW; Lee WH; Lee SB; Park YS; Jhoo JH; Lee DY; Kim KW
Dement Geriatr Cogn Disord; 2008; 25(4):321-8. PubMed ID: 18319591
[TBL] [Abstract][Full Text] [Related]
4. Visuospatial dysfunction may be a key in the differentiation between Alzheimer's disease and subcortical cognitive impairment in moderate to severe stages.
Fukui T; Lee E; Kitamura M; Hosoda H; Bokui C; Ikusu K; Okita K
Dement Geriatr Cogn Disord; 2009; 28(4):288-94. PubMed ID: 19828949
[TBL] [Abstract][Full Text] [Related]
5. Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease.
Burns T; Mortimer JA; Merchak P
J Geriatr Psychiatry Neurol; 1994; 7(1):46-54. PubMed ID: 8192830
[TBL] [Abstract][Full Text] [Related]
6. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
[TBL] [Abstract][Full Text] [Related]
7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
8. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
[TBL] [Abstract][Full Text] [Related]
9. [Measuring cognitive change in patients with suspected dementia--change norms are lacking for psychometric instruments].
Hensel A; Riedel-Heller SG
Psychiatr Prax; 2008 Jul; 35(5):251-4. PubMed ID: 17806007
[TBL] [Abstract][Full Text] [Related]
10. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
11. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
[TBL] [Abstract][Full Text] [Related]
12. Influence of education on the pattern of cognitive deterioration in AD patients: the cognitive reserve hypothesis.
Le Carret N; Auriacombe S; Letenneur L; Bergua V; Dartigues JF; Fabrigoule C
Brain Cogn; 2005 Mar; 57(2):120-6. PubMed ID: 15708201
[TBL] [Abstract][Full Text] [Related]
13. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
[TBL] [Abstract][Full Text] [Related]
14. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
15. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
[TBL] [Abstract][Full Text] [Related]
16. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
17. Japanese version of the Frontal Assessment Battery for dementia.
Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S
Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465
[TBL] [Abstract][Full Text] [Related]
18. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?].
Sarazin M; Dubois B
Rev Neurol (Paris); 2002; 158(10 Suppl):S30-4. PubMed ID: 12529583
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
20. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
